Lamin A/C Antikörper

Produktnummer ABIN335389

Produktdetails anti-Lamin A/C Antikörper

Target: Lamin A/C (LMNA)

Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Lamin A/C Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))

Spezifität: Human, rat, mouse, bovine, dog.

Aufreinigung: Purified

Immunogen: 133A2 is a mouse monoclonal IgG3/kappa antibody obtained from fusion of P3/X63.Ag8.653 mouse myeloma cells with spleen cells from a BALB/c mouse immunized with partially purified recombinant human lamin A.

Klon: 133A2

Isotyp: IgG3

Anwendungsinformationen

Applikationshinweise: 133A2 recognizes an epitope located between residues 598-611 of lamin A and therefore 133A2 reacts exclusively with lamin A. 133A2 is suitable for immunocytochemistry, immunohistochemistry on frozen sections, immunoblotting and flow cytometry. Optimal antibody dilution should be determined by titration, recommended range is 1:100 - 1:200 for flow cytometry, and for immunohistochemistry with avidin-biotinylated horseradish peroxidase complex (ABC) as detection reagent, and 1:100 - 1:1000 for immunoblotting applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C

Referenzen für anti-Lamin A/C Antikörper (ABIN335389)

Broers, Bronnenberg, Kuijpers, Schutte, Hutchison, Ramaekers: "Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis." in: European journal of cell biology, Vol. 81, Issue 12, pp. 677-91, (2003) (PubMed).

Broers, Machiels, van Eys, Kuijpers, Manders, van Driel, Ramaekers: "Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins." in: Journal of cell science, Vol. 112 ( Pt 20), pp. 3463-75, (2000) (PubMed).

Neri, Raymond, Giordano, Borgatti, Marchisio, Capitani, Martelli: "Spatial distribution of lamin A and B1 in the K562 cell nuclear matrix stabilized with metal ions." in: Journal of cellular biochemistry, Vol. 75, Issue 1, pp. 36-45, (1999) (PubMed).

Neri, Raymond, Giordano, Capitani, Martelli: "Lamin A is part of the internal nucleoskeleton of human erythroleukemia cells." in: Journal of cellular physiology, Vol. 178, Issue 3, pp. 284-95, (1999) (PubMed).

Pugh, Coates, Lane, Raymond, Quinlan: "Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells." in: Journal of cell science, Vol. 110 ( Pt 19), pp. 2483-93, (1997) (PubMed).

Broers, Machiels, Kuijpers, Smedts, van den Kieboom, Raymond, Ramaekers: "A- and B-type lamins are differentially expressed in normal human tissues." in: Histochemistry and cell biology, Vol. 107, Issue 6, pp. 505-17, (1997) (PubMed).

Jansen, Machiels, Hopman, Broers, Bot, Arends, Ramaekers, Schouten: "Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease." in: Histopathology, Vol. 31, Issue 4, pp. 304-12, (1997) (PubMed).

Machiels, Ramaekers, Kuijpers, Groenewoud, Oosterhuis, Looijenga: "Nuclear lamin expression in normal testis and testicular germ cell tumours of adolescents and adults." in: The Journal of pathology, Vol. 182, Issue 2, pp. 197-204, (1997) (PubMed).

Machiels, Broers, Raymond, de Ley, Kuijpers, Caberg, Ramaekers: "Abnormal A-type lamin organization in a human lung carcinoma cell line." in: European journal of cell biology, Vol. 67, Issue 4, pp. 328-35, (1996) (PubMed).

Hozák, Sasseville, Raymond, Cook: "Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells." in: Journal of cell science, Vol. 108 ( Pt 2), pp. 635-44, (1995) (PubMed).

Details zu Lamin A/C

Target: Lamin A/C (LMNA)

Andere Bezeichnung: Lamin A (LMNA Produkte)

Synonyme: CDCD1 antikoerper, CDDC antikoerper, CMD1A antikoerper, CMT2B1 antikoerper, EMD2 antikoerper, FPL antikoerper, FPLD antikoerper, FPLD2 antikoerper, HGPS antikoerper, IDC antikoerper, LDP1 antikoerper, LFP antikoerper, LGMD1B antikoerper, LMN1 antikoerper, LMNC antikoerper, LMNL1 antikoerper, PRO1 antikoerper, Dhe antikoerper, 2459 antikoerper, 74/76 antikoerper, CG6944 antikoerper, D5 antikoerper, DM[[O]] antikoerper, Dm antikoerper, Dm(0) antikoerper, Dm0 antikoerper, Dm1 antikoerper, Dm2 antikoerper, DmLamin antikoerper, DmO antikoerper, Dm[[0]] antikoerper, Dm[[1]] antikoerper, Dm[[2]] antikoerper, Dm[[mit]] antikoerper, Dm[[o]] antikoerper, Dmel\\CG6944 antikoerper, Dmo antikoerper, LAM antikoerper, Lam Dm[[0]] antikoerper, Lam(Dm0) antikoerper, LamDm[[0]] antikoerper, LamDm[[o]] antikoerper, Lam[[Dm0]] antikoerper, Lamin Dm[[0]] antikoerper, jf27 antikoerper, l(2)04643 antikoerper, l(2)25Ec antikoerper, l(2)gdh-7 antikoerper, l(2)gdh7 antikoerper, l(2)jf27 antikoerper, lam antikoerper, lamDm0 antikoerper, lamDm[[0]] antikoerper, lamin antikoerper, lamin Dm0 antikoerper, lamin Dm[[0]] antikoerper, misg antikoerper, nlam antikoerper, cb948 antikoerper, fk66d12 antikoerper, wu:fk66d12 antikoerper, lmna-A antikoerper, fpl antikoerper, idc antikoerper, lfp antikoerper, cddc antikoerper, emd2 antikoerper, fpld antikoerper, hgps antikoerper, ldp1 antikoerper, lmn1 antikoerper, lmnc antikoerper, pro1 antikoerper, cdcd1 antikoerper, cmd1a antikoerper, cmt2b1 antikoerper, lgmd1b antikoerper, Lamin-A antikoerper, lamin-L(III)-like antikoerper, lamin A/C antikoerper, lamin A antikoerper, Lamin antikoerper, lamin A/C L homeolog antikoerper, lamin-L(III)-like antikoerper, LMNA antikoerper, Lmna antikoerper, Lam antikoerper, lmna antikoerper, lmna.L antikoerper, LMINA antikoerper

Hintergrund: Nuclear lamins form a network of intermediate-type filaments at the nucleoplasmic site of the nuclear membrane. Two main subtypes of nuclear lamins can be distinguished, i.e. A-type lamins and B-type lamins. The A-type lamins comprise a set of three proteins arising from the same gene by alternative splicing, i.e. lamin A, lamin C and lamin Adel 10, while the B-type lamins include two proteins arising from two distinct genes, i.e. lamin B1 and lamin B2. Recent evidence has revealed that mutations in A-type lamins give rise to a range of rare but dominant genetic disorders, including Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy with conduction-system disease and Dunnigan-type familial partial lipodystrophy. In addition, the expression of A-type lamins coincides with cell differentiation and as A-type lamins specifically interact with chromatin, a role in the regulation of differential gene expression has been suggested for A-type lamins.

Pathways: Apoptose, Caspase Kaskade in der Apoptose, ER-Nucleus Signaling, Protein targeting to Nucleus